More about High-Yield Cash Accounts with M1
Brokerage Accounts
Retirement Accounts
Other Accounts
Quotes are delayed by 15 minutes.
1D
1W
1M
3M
6M
YTD
1Y
2Y
5Y
ALL
Market cap
$1.77B
EPS
-0.05
P/E ratio
--
Price to sales
8.24
Dividend yield
--
Beta
0.994603
Previous close
$35.30
Today's open
$35.08
Day's range
$34.81 - $35.89
52 week range
$9.22 - $36.00
show more
CEO
Michael Dale
Employees
451
Headquarters
Alachua, FL
Exchange
NASDAQ Capital Market
Shares outstanding
50117283
Issue type
Common Stock
Healthcare
Medical Equipment & Supplies
HighMark Wealth Management Buys 158,855 Shares of Axogen Stock
HighMark Wealth Management LLC added 158,855 shares of Axogen. The quarter-end value of the stake rose by $7.9 million, reflecting both trading activity and share price movement.
The Motley Fool • 13 hours ago

Axogen, Inc. (AXGN) Q4 2025 Earnings Call Transcript
Axogen, Inc. (AXGN) Q4 2025 Earnings Call Transcript
Seeking Alpha • 10 hours ago

AxoGen (AXGN) Q4 Earnings Miss Estimates
AxoGen (AXGN) came out with quarterly earnings of $0.07 per share, missing the Zacks Consensus Estimate of $0.14 per share. This compares to earnings of $0.08 per share a year ago.
Zacks Investment Research • 11 hours ago

First Eagle Small Cap Opportunity Fund Q4 2025 Portfolio Review
First Eagle Small Cap Opportunity Fund A Shares (without sales charge*) posted a return of 1.71% in fourth quarter 2025. Small Cap Opportunity Fund A Shares (without sales charge*) posted a return of 1.71% in fourth quarter 2025.
Seeking Alpha • Feb 19, 2026

Axogen, Inc. to Participate in Multiple Upcoming Investor Conferences
ALACHUA, Fla. and TAMPA, Fla., Feb. 17, 2026 (GLOBE NEWSWIRE) -- Axogen, Inc. (Nasdaq: AXGN), a global leader in developing and marketing innovative surgical solutions for the restoration of peripheral nerve function, today announced that management is scheduled to participate in three upcoming investor conferences:
GlobeNewsWire • Feb 17, 2026

Axogen, Inc. to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026
ALACHUA, Fla. and TAMPA, Fla., Feb. 10, 2026 (GLOBE NEWSWIRE) -- Axogen, Inc. (Nasdaq: AXGN), a global leader in developing and marketing innovative surgical solutions for the restoration of peripheral nerve function, today announced that it will release financial results for the fourth quarter and full year 2025 on Tuesday, February 24, 2026. Axogen management will host an investment-community conference call and webcast at 8:00 a.m. ET following the release.
GlobeNewsWire • Feb 10, 2026

Wasatch Micro Cap Fund Q4 2025 Performance Review
Leading individual contributors to the Fund's relative performance included Axogen, Inc., a holding within the health-care equipment industry. A provider of prepared food items such as meatballs and paninis, Mama's targets the deli area of grocery stores and warehouse clubs. On the downside, software distribution company Climb Global Solutions, Inc. was the Fund's leading laggard in the quarter.
Seeking Alpha • Feb 4, 2026

Axogen Announces Proposed Public Offering of Common Stock
ALACHUA, Fla. and TAMPA, Fla.
GlobeNewsWire • Jan 21, 2026

Axogen Announces Pricing of Upsized $124 Million Public Offering of Common Stock
ALACHUA, Fla. and TAMPA, Fla.
GlobeNewsWire • Jan 22, 2026

Axogen, Inc. (AXGN) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Axogen, Inc. (AXGN) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Seeking Alpha • Jan 15, 2026

¹ Disclosures

Open an M1 investment account to buy and sell Axogen Inc. commission-free¹. Build wealth for the long term using automated trading and transfers.